Details For Selected Brain Tumor Treatment
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

Back to New Treatments List Back to New Treatments List

Treatment Name: Study of a Retroviral Replicating Vector (Tocagen Toca 511) to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Phase: Phase 1
Treatment ID#: 2033        
Age Group: Adults Only
Min Karnofsky Score: 70: Cares for self, unable to perform normal activity or to do active work
Conditions: Prior Surgery is Allowed
Prior Radiation is Allowed
Prior Chemotherapy is Allowed
Last Updated: 07/16/2012
Tumor Types: Anaplastic Astrocytoma
Any Malignant Brain Tumor
Glioblastoma Multiforme
Oligodendroglioma High Grade
Recurrent Malignant Pediatric Brain Tumors
Treatment Type: Surgery
Gene Therapy
Contact: Dr.Tom MikKelsen MD, FRCP(C)
Henry Ford Hospital
Hermelin Brain Tumor Center
E&R3096 Henry Ford Hospital 2799 West Grand Blvd
Detroit, MI 48202- USA
Phone: 313 916-8641
Fax: 313 916-9855
  • Last updated refers to the date when our listing for each treatment was last updated.
  • ID is a combination of our internal ID and the official ID for the trial, if any.
  • Min Karnofsky is a general guide to how well you have to function to use this treatment

Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

Copyright (c) 1993 - 2015 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites